drugset
drugset / Trial / NCT03564379

A Single and Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of JNJ-42165279 in Healthy Japanese Male Participants

NCT03564379 ↗

Phase 1 Completed 12 enrolled Janssen Research & Development, LLC
RandomizedSequentialDouble-blindOther

Summary

The purpose of this study is to assess the safety, tolerability, and pharmacokinetics of JNJ-42165279 in healthy Japanese male participants after single and multiple oral dose administration.

Timeline

Start
2018-06-12
Primary completion
2018-08-13
Completion
2018-08-13

Drugs

EvaluationDrugModalityDoseRoute
Subject JNJ-42165279 Small molecule 25 mg Oral

Indications

No indication recorded.